Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
US9169199B2 · kind B2 · utility
8Cited by
7References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2011 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Apr 18, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides cycloalkyl guanidine compounds that inhibit F1F0-ATPase, and methods of using cyclalkyl guanidine compounds as therapeutic agents in therapy, such as treating an immune disorder, inflammatory condition, or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.